{"name":"Domain Therapeutics SA","slug":"domain-therapeutics-sa","ticker":"","exchange":"","domain":"domain.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE13ZnR2bzdYbzIzN3FIVmp3cXYyTlpEM19wRHBCVE5rdy12Qk9xM3JJb2l6VWI2TnRTb0lJX2FFeTRQYkp0ZDFmWG1RMjV2ZENhRkRvRGI2NEZMc2VlcDhr?oc=5","date":"2026-01-08","type":"pipeline","source":"Nature","summary":"Impact of drug repurposing between 1985 and 2024 on pharmaceutical innovation - Nature","headline":"Impact of drug repurposing between 1985 and 2024 on pharmaceutical innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNWk5QY1A2c0Ryc0dobWlGYk1rdUZpQnVNeXQ4NWh2RENmMXh2UjNzcXJXU1piVEstcElUSk82Q2ZXUFhDaHo4SE1uamJBdDJ5LWFoTHZ2UUNTdFB0b3ZuNzUxaXlyMVU3SnFobTdlOFBwZzRrTVlJVHZVV2M1UTZSWThfMngtS1pFRVJr?oc=5","date":"2025-12-04","type":"trial","source":"Yahoo Finance","summary":"Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Yahoo Finance","headline":"Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Dom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQV1JBcWNmYk85cFJyVU9PYzE1c0x3b2RjcW9fN1JUQ1FNc1BRUjNMRkltMTl3cHZCdnpoOHFvQlFCY3BrQ0ZWa1lxQnNCb055NlZyVlcwelZGd1hxRmhCVnBybXdSS1B3eFJZT1JUV0JfWGFEM2Vvc3ZJNzdRdUlPcmR4YkJjSEEyWGhIYm0xZkk0cXJLTzNXeXR3anY5cjA4eEQwbzNVWjUtSWxDdm55Ti0zWFh3TW8zUnlRcmpVTFhQc0NCMmJydTdVUzBYbXdGbGR5R2xPeWNLX3VuV0t6bWduNW1GYnhSYl8zbmFfa2lteDBGTzNtQUlKNHlOczZjYXFISHdpc3dtUm9IY0FCNmQwZ2hPeEhYdTAwaFFwTXlGd2Z4NHdpbUxiZXU1dGM5UjBrVjQ2UTc5QlJkM0NyUVlQWnBQTkU?oc=5","date":"2025-03-05","type":"trial","source":"GlobeNewswire","summary":"CAR T-cell Therapy Clinical Trial Pipeline Experiences - GlobeNewswire","headline":"CAR T-cell Therapy Clinical Trial Pipeline Experiences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxOenZwWnVZZTJIRTVqNlF5cEJwZHhzWGFMay1aYVVsN2l3b3BEWHpkYU5VN1BJSlhYa2kzMlAwZ09EMFJEZXdTNXJzajVYLVdZWUJrRHAza3ZreGY1UlRNaWUwYUl0cEQ2NFJPMEJJelFoWWYxMWRZOVE3UmQydDRQRk5oVTloaEdhUEZCVXJPZmpGSEVPcWZ6ZFBueTdOdmlpSDVJQmVhZkVkWVByNEZETGxPc1lBNXFKanpRWllUaHVWZTJmRVR5aDlVelpvYXk4LWpPT2hmZFVOOWV4Z1Q0cEVZUDBINEk2QVpsWDFCOERfQmxMWnQwQlloT3NoVGVsTnA2NXQ5VHVjRDhBdjctTUw1bmFFT0xwclJSQ2QwdE1CUFMtV3JsbW1PTQ?oc=5","date":"2024-10-22","type":"trial","source":"PR Newswire","summary":"JAK Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 50+ Companies Working in the Domain - PR Newswire","headline":"JAK Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 50+ Co","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxORVFEdVh2b3ZPNnhVVlU0Z0xzdlpnOTZCbi1ZSUFhM2lWMnoya1IySEtiRVB0Tl9UV3ozQ3M5T0pRZ0xjRnpCR1RjYUt4ekd0YW5OT29YcjAxM3FObF9fRmZfMWstc2lLdkNsNi1ZVkQ1aHlMWFZnTThNQmpYcmVQQzhscTZXcFBLRnZuQWxjR0M2WDVfMlBjWnRXcG1zSGlyREZzYzV4VWFOS1NGSEpaOWQ1ck9vRUVQaWhSRFZGQ0YyS1BfMkVPTlhpX3NtS0Frd0tOdEhxTWNOSHlpNUVJVWd2SWNJQzZiTU9VQg?oc=5","date":"2024-10-16","type":"pipeline","source":"GlobeNewswire","summary":"80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - GlobeNewswire","headline":"80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxQVGhLNGF1QzFjZ2Y2dG8zLXBVSVZoaENDTWFFeW9nZ0otZmRYNHZqWlZ4U1FjNm5BazBURzlwc1IyWmJEcHoxcjRYdHV6V1pENDVDUXc2WENJV3FYNHVibmhpZEJGTkNaOWRpbDNVSmdRMzBXSEl6MmI3R0dfQ0VORnptSDdHSTVfMWpuM25hc3JZQTVuNnhidlRaZFpTZmE5U2RoWE5XMllIQlk1Z1RhVkJHV3B4a1ZGUWxmZGxhN2hpR2RNQkRsZ2JWZjNQTHBKLU1hMy00a0NndHlOb215OE9NZ1U5WklzWnVaZXJZVTNDZWM2Z0hYZDhWdThaUVp6ZG9CbldRSkZDTXc2R3ZnRFd3TDlkZ3ZPaDVtLXJxWlFySG1ZUjA4d2dRVjNOdlVLU1V1Vg?oc=5","date":"2024-09-24","type":"trial","source":"GlobeNewswire","summary":"Renal Cancer Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Renal Cancer Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-05-31","type":"trial","source":"GlobeNewswire","summary":"B-Cell Lymphoma Clinical Trial Pipeline Insights: - GlobeNewswire","headline":"B-Cell Lymphoma Clinical Trial Pipeline Insights:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBmYzdHUDdSMmlaQ3FydGVhRFJlVTY4dTU1YXVwaVJuU2lKVGwzWXVjSFNGckdZaUlrSXppdVJwVmk3UTJzd0hka3JxY0lJUXdWd3lxZ2FvdWNEeHdwNG5J?oc=5","date":"2023-05-11","type":"pipeline","source":"Nature","summary":"Applications of synthetic biology in medical and pharmaceutical fields - Nature","headline":"Applications of synthetic biology in medical and pharmaceutical fields","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxQNU56YXp3SXVHRGlSLWxQTm1BdHdmN3dCeEdIakdOSHUxWEJ6ZGl6SlJfeWNUTnJDdW5SRjZCUHM0WVljTXFmMmhkWkhLS3dVY1lhWENJV2dvVzFiM1pvRlJCVE9rcUxvQlJwV3VpRzhSLUQycjI3ZzJ5RGI0Ulc0MzFJMGxYeDl4ZUxkUXBpVmxqa1dqakhKY0hNcExNX0FkQUpuZEVCd2sycjBXOTNPcnBXbVlyTkpubmNaX0NUYmFkTUVlUkk1OUZxeWVkYWtOaXJNNmpYdEFqUUJXQjJaUmQ0czhVcG43ZV82OE9CbHA5am1odlMzQ0N5WGZFX1Q4VkxvbjZKTFN0aE8zRE92V1NYNXlBRjBYY0k2M2VIU2oyVXM?oc=5","date":"2023-01-30","type":"pipeline","source":"PR Newswire","summary":"Acute Myeloid Leukemia Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 200+ Companies Working in the Domain - PR Newswire","headline":"Acute Myeloid Leukemia Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 200+ Companie","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}